Fernanda Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fernanda Santos has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Margarida Figueiredo-Dias
Faculty of Medicine, Gynecology Department, University of Coimbra, 3004-504 Coimbra, Portugal
3 shared publications - Francisco Caramelo
Laboratory of Biostatistics and Medical Informatics (LBIM), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal
2 shared publications Isabel Santos Silva
Serviço de Ginecologia e Obstetrícia B. Centro Hospitalar e Universitário de Coimbra. Coimbra
2 shared publications- Jorge M. P. Tomaz
Blood and Transfusion Medicine Department, ULS—Coimbra Hospital and University Centre of Coimbra, 3004-561 Coimbra, Portugal
2 shared publications - Luís Pereira de Almeida
Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal
2 shared publications - Magda M. Santana
Center for Neuroscience and Cell Biology, University of Coimbra (CNC-UC), Coimbra, Portugal
2 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (10)
Operationalizing cervical cancer elimination: a health-system archetype framework for implementation
- 6 October 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (10)
Open AccessOperationalizing cervical cancer elimination: a health-system archetype framework for implementation
- Open Access
- 7 September 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (12) , 5978-5983
Second trimester adnexal torsion of a large ovarian mature teratoma: Diagnostic value of whirlpool sign
- 7 September 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (12) , 5978-5983
Open AccessSecond trimester adnexal torsion of a large ovarian mature teratoma: Diagnostic value of whirlpool sign
- Open Access
- 17 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6372
Cell-Free DNA Fragmentation Patterns as Biomarkers for Human Papillomavirus-Related Cancers: A Systematic Review of Methodological Diversity and Diagnostic Performance
Novel blood biomarkers are crucial for HPV-related cancers to overcome the limitations of imaging and biopsies. This review evaluates the diagnostic performance of circulating cell-free DNA (cfDNA) fragmentomic patterns, distinguishing host-genome integrity from specific viral signatures. Following PRISMA guidelines, we searched PubMed, EMBASE, and Web of Science up to February 2026. Methodological quality was assessed via QUADAS-2, and diagnostic performance was synthesized using a random-effects model. From 489 records, six studies (215 patients, 209 controls) met inclusion criteria. Lacking host-derived fragmentomics data, the analysis focused exclusively on the structural size profiles of circulating viral DNA (cfHPV-DNA). Meta-analysis of four cohorts specifically evaluating these viral fragmentation patterns yielded a pooled Diagnostic Odds Ratio (DOR) of 205.73 (95% CI: 44.72–946.38). Specificity was robust (~100%), with high sensitivity (>90%) for macroscopic disease. However, sensitivity decreased in low-tumor-burden cohorts. cfHPV-DNA fragmentation patterns shows promising diagnostic potential for macroscopic HPV-driven malignancies. However, further studies must determine whether fragment sizing truly outperforms binary viral detection and correlates with disease severity. Furthermore, while current assays exploit the analytical simplicity of viral targets, host-derived fragmentomics remains an overlooked compartment that warrants exploration to determine its true clinical value regarding underlying tumor dynamics. Systematic Review Registration: PROSPERO, identifier: CRD420251052768.
- 17 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6372
Open AccessCell-Free DNA Fragmentation Patterns as Biomarkers for Human Papillomavirus-Related Cancers: A Systematic Review of Methodological Diversity and Diagnostic Performance
Novel blood biomarkers are crucial for HPV-related cancers to overcome the limitations of imaging and biopsies. This review evaluates the diagnostic performance of circulating cell-free DNA (cfDNA) fragmentomic patterns, distinguishing host-genome integrity from specific viral signatures. Following PRISMA guidelines, we searched PubMed, EMBASE, and Web of Science up to February 2026. Methodological quality was assessed via QUADAS-2, and diagnostic performance was synthesized using a random-effects model. From 489 records, six studies (215 patients, 209 controls) met inclusion criteria. Lacking host-derived fragmentomics data, the analysis focused exclusively on the structural size profiles of circulating viral DNA (cfHPV-DNA). Meta-analysis of four cohorts specifically evaluating these viral fragmentation patterns yielded a pooled Diagnostic Odds Ratio (DOR) of 205.73 (95% CI: 44.72–946.38). Specificity was robust (~100%), with high sensitivity (>90%) for macroscopic disease. However, sensitivity decreased in low-tumor-burden cohorts. cfHPV-DNA fragmentation patterns shows promising diagnostic potential for macroscopic HPV-driven malignancies. However, further studies must determine whether fragment sizing truly outperforms binary viral detection and correlates with disease severity. Furthermore, while current assays exploit the analytical simplicity of viral targets, host-derived fragmentomics remains an overlooked compartment that warrants exploration to determine its true clinical value regarding underlying tumor dynamics. Systematic Review Registration: PROSPERO, identifier: CRD420251052768.
- Open Access
Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis
Background/Objectives: Cervical cancer remains a significant global health burden, underscoring the imperative for refined diagnostic and prognostic methodologies. This study aimed to evaluate the potential of extracellular vesicles (EVs) as non-invasive biomarkers for cervical cancer, focusing on diagnosis and prognosis. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines to assess the diagnostic and prognostic accuracy of EV-based biomarkers. We searched PubMed, EMBASE, and Web of Science for relevant studies. Twelve articles met the inclusion criteria: eight related to diagnostic accuracy, three to prognosis, and one to both outcomes. Six studies met the criteria for meta-analysis. We used a random-effects model to synthesise diagnostic data, while prognostic data were synthesised narratively. Results: The meta-analysis yielded a pooled area under the receiver operating characteristic curve (AUC) of 0.87 (95% CI 0.80–0.92) for EVs in the diagnosis of cervical cancer, indicating high accuracy. The evaluated diagnostic biomarkers were primarily non-coding RNAs. For prognosis, data heterogeneity precluded quantitative synthesis; however, individual studies identified diverse EV-associated molecules correlated with recurrence and survival. GRADE assessment indicated a high risk of bias and heterogeneity across studies. Conclusions: Extracellular vesicles demonstrate robust promise as diagnostic biomarkers for cervical cancer; however, their prognostic utility remains inconclusive due to methodological and clinical heterogeneity. Future research must prioritise the standardisation of isolation protocols and the execution of large-scale, prospective studies to validate EV biomarkers for clinical application. Systematic Review Registration: PROSPERO, identifier: CRD420251014411.
Open AccessExosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis
Background/Objectives: Cervical cancer remains a significant global health burden, underscoring the imperative for refined diagnostic and prognostic methodologies. This study aimed to evaluate the potential of extracellular vesicles (EVs) as non-invasive biomarkers for cervical cancer, focusing on diagnosis and prognosis. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines to assess the diagnostic and prognostic accuracy of EV-based biomarkers. We searched PubMed, EMBASE, and Web of Science for relevant studies. Twelve articles met the inclusion criteria: eight related to diagnostic accuracy, three to prognosis, and one to both outcomes. Six studies met the criteria for meta-analysis. We used a random-effects model to synthesise diagnostic data, while prognostic data were synthesised narratively. Results: The meta-analysis yielded a pooled area under the receiver operating characteristic curve (AUC) of 0.87 (95% CI 0.80–0.92) for EVs in the diagnosis of cervical cancer, indicating high accuracy. The evaluated diagnostic biomarkers were primarily non-coding RNAs. For prognosis, data heterogeneity precluded quantitative synthesis; however, individual studies identified diverse EV-associated molecules correlated with recurrence and survival. GRADE assessment indicated a high risk of bias and heterogeneity across studies. Conclusions: Extracellular vesicles demonstrate robust promise as diagnostic biomarkers for cervical cancer; however, their prognostic utility remains inconclusive due to methodological and clinical heterogeneity. Future research must prioritise the standardisation of isolation protocols and the execution of large-scale, prospective studies to validate EV biomarkers for clinical application. Systematic Review Registration: PROSPERO, identifier: CRD420251014411.
- Open Access
- 31 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13507
New Insights into Photobiomodulation of the Vaginal Microbiome—A Critical Review
The development of new technologies such as sequencing has greatly enhanced our understanding of the human microbiome. The interactions between the human microbiome and the development of several diseases have been the subject of recent research. In-depth knowledge about the vaginal microbiome (VMB) has shown that dysbiosis is closely related to the development of gynecologic and obstetric disorders. To date, the progress in treating or modulating the VMB has lagged far behind research efforts. Photobiomodulation (PBM) uses low levels of light, usually red or near-infrared, to treat a diversity of conditions. Several studies have demonstrated that PBM can control the microbiome and improve the activity of the immune system. In recent years, increasing attention has been paid to the microbiome, mostly to the gut microbiome and its connections with many diseases, such as metabolic disorders, obesity, cardiovascular disorders, autoimmunity, and neurological disorders. The applicability of PBM therapeutics to treat gut dysbiosis has been studied, with promising results. The possible cellular and molecular effects of PBM on the vaginal microbiome constitute a theoretical and promising field that is starting to take its first steps. In this review, we will discuss the potential mechanisms and effects of photobiomodulation in the VMB.
- 31 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13507
Open AccessNew Insights into Photobiomodulation of the Vaginal Microbiome—A Critical Review
The development of new technologies such as sequencing has greatly enhanced our understanding of the human microbiome. The interactions between the human microbiome and the development of several diseases have been the subject of recent research. In-depth knowledge about the vaginal microbiome (VMB) has shown that dysbiosis is closely related to the development of gynecologic and obstetric disorders. To date, the progress in treating or modulating the VMB has lagged far behind research efforts. Photobiomodulation (PBM) uses low levels of light, usually red or near-infrared, to treat a diversity of conditions. Several studies have demonstrated that PBM can control the microbiome and improve the activity of the immune system. In recent years, increasing attention has been paid to the microbiome, mostly to the gut microbiome and its connections with many diseases, such as metabolic disorders, obesity, cardiovascular disorders, autoimmunity, and neurological disorders. The applicability of PBM therapeutics to treat gut dysbiosis has been studied, with promising results. The possible cellular and molecular effects of PBM on the vaginal microbiome constitute a theoretical and promising field that is starting to take its first steps. In this review, we will discuss the potential mechanisms and effects of photobiomodulation in the VMB.
- 31 March 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (4) , 258-265
Salpingectomia Profilática como Método de Contraceção Definitiva: Estudo Transversal em Portugal
Introdução: A salpingectomia profilática foi proposta como estratégia de redução do risco de cancro do ovário e método de contraceção definitiva. O objetivo deste estudo foi conhecer os procedimentos realizados a nível nacional para contraceção definitiva de intervalo e peri-parto, a opinião e motivações dos clínicos, e os fatores demográficos ou profissionais influentes.Material e Métodos: Este é um estudo analítico transversal, baseado num questionário original enviado durante o ano de 2019 a especialistas e internos de Ginecologia-Obstetrícia a exercer em Portugal.Resultados: Obtivemos 225 respostas provenientes de médicos a exercer em 42 hospitais (37 públicos). A laqueação tubar laparoscópica por eletrocoagulação e corte (61%) foi o método mais frequentemente utilizado na mulher não grávida, seguido da salpingectomia (28%). Os principais motivos apontados para não realizar salpingectomia foram o aumento do tempo operatório (48,5%) e tratar-se de procedimento não equacionado (45,5%). Em alguns hospitais, a realização deste método dependia da decisão da equipa cirúrgica. No contexto per-cesariana, a técnica mais comum foi a de Pomeroy modificada (54%), seguida da salpingectomia (32,5%), com uma concentração no Norte do país com significado estatístico. A maioria (69%) dos participantes consideraram que a salpingectomia deveria ser o procedimento disponibilizado.Discussão: Apesar da evidência científica ainda ser escassa, a salpingectomia per-cesariana parece exequível e segura, podendo representar a melhor oportunidade para intervenção no contexto da contraceção definitiva.Conclusão: A salpingectomia profilática não é o procedimento de esterilização mais comum em Portugal, mas foi considerada como a escolha mais adequada. Os seus benefícios e riscos devem ser discutidos com as mulheres.
- 31 March 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (4) , 258-265
Salpingectomia Profilática como Método de Contraceção Definitiva: Estudo Transversal em Portugal
Introdução: A salpingectomia profilática foi proposta como estratégia de redução do risco de cancro do ovário e método de contraceção definitiva. O objetivo deste estudo foi conhecer os procedimentos realizados a nível nacional para contraceção definitiva de intervalo e peri-parto, a opinião e motivações dos clínicos, e os fatores demográficos ou profissionais influentes.Material e Métodos: Este é um estudo analítico transversal, baseado num questionário original enviado durante o ano de 2019 a especialistas e internos de Ginecologia-Obstetrícia a exercer em Portugal.Resultados: Obtivemos 225 respostas provenientes de médicos a exercer em 42 hospitais (37 públicos). A laqueação tubar laparoscópica por eletrocoagulação e corte (61%) foi o método mais frequentemente utilizado na mulher não grávida, seguido da salpingectomia (28%). Os principais motivos apontados para não realizar salpingectomia foram o aumento do tempo operatório (48,5%) e tratar-se de procedimento não equacionado (45,5%). Em alguns hospitais, a realização deste método dependia da decisão da equipa cirúrgica. No contexto per-cesariana, a técnica mais comum foi a de Pomeroy modificada (54%), seguida da salpingectomia (32,5%), com uma concentração no Norte do país com significado estatístico. A maioria (69%) dos participantes consideraram que a salpingectomia deveria ser o procedimento disponibilizado.Discussão: Apesar da evidência científica ainda ser escassa, a salpingectomia per-cesariana parece exequível e segura, podendo representar a melhor oportunidade para intervenção no contexto da contraceção definitiva.Conclusão: A salpingectomia profilática não é o procedimento de esterilização mais comum em Portugal, mas foi considerada como a escolha mais adequada. Os seus benefícios e riscos devem ser discutidos com as mulheres.
- Open Access
- 28 June 2019
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 32 (6) , 453-458
Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study
Introduction: Skin and skin structure infections are an increasing cause of hospitalization. Although mortality is relatively low, skin and skin structure infections are associated with prolonged hospital length of stay and high costs. Oxazolidinones have been suggested as a tool to treat infected patients in the ambulatory setting in order to decrease hospital length of stay. We wanted to address the evidence associated with the use of oxazolidinones in the treatment of skin and skin structure infections.Material and Methods: In this observational retrospective study we analyzed the anonymized diagnosis related group coded information from the Portuguese database for hospital admissions, that included all adult patients with a diagnosis of oxazolidinone use and a SSSI, discharged between 2010 and 2015.Results: During the study period, a total of 5518 patients had a diagnosis of oxazolidinone treatment. We selected 483 of those who were also diagnosed with a skin and skin structure infections. Their mean age was 64.9 years and 62.7% were male. The median hospital length of stay was 27 days (Inter quartile range 13 – 56) and the mortality rate was 12.6%. The prevalence of secondary anemia and of thrombocytopenia in the whole group treated with oxazolidinones was 2.5% and 3%, respectively.Discussion: Despite the high bioavailability of oxazolidinones, we were not able to find evidence that its use was associated with a decrease of mortality or hospital length of stay (due to early discharge) of patients with skin and skin structure infections.Conclusion: In this study we were not able to find evidence that oxazolidinones had any clinically significant benefit. A structured approach, including antibiotics with favorable pharmacokinetic and safety profile as well as a carefully planned ambulatory follow up may be needed.
- 28 June 2019
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 32 (6) , 453-458
Open AccessEvidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study
Introduction: Skin and skin structure infections are an increasing cause of hospitalization. Although mortality is relatively low, skin and skin structure infections are associated with prolonged hospital length of stay and high costs. Oxazolidinones have been suggested as a tool to treat infected patients in the ambulatory setting in order to decrease hospital length of stay. We wanted to address the evidence associated with the use of oxazolidinones in the treatment of skin and skin structure infections.Material and Methods: In this observational retrospective study we analyzed the anonymized diagnosis related group coded information from the Portuguese database for hospital admissions, that included all adult patients with a diagnosis of oxazolidinone use and a SSSI, discharged between 2010 and 2015.Results: During the study period, a total of 5518 patients had a diagnosis of oxazolidinone treatment. We selected 483 of those who were also diagnosed with a skin and skin structure infections. Their mean age was 64.9 years and 62.7% were male. The median hospital length of stay was 27 days (Inter quartile range 13 – 56) and the mortality rate was 12.6%. The prevalence of secondary anemia and of thrombocytopenia in the whole group treated with oxazolidinones was 2.5% and 3%, respectively.Discussion: Despite the high bioavailability of oxazolidinones, we were not able to find evidence that its use was associated with a decrease of mortality or hospital length of stay (due to early discharge) of patients with skin and skin structure infections.Conclusion: In this study we were not able to find evidence that oxazolidinones had any clinically significant benefit. A structured approach, including antibiotics with favorable pharmacokinetic and safety profile as well as a carefully planned ambulatory follow up may be needed.
- 1 April 2017
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 27, 1-74
LiFE | Literature for ENYGO
- 1 April 2017
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 27, 1-74
LiFE | Literature for ENYGO